Exodus Point Capital Management, LP Maravai Lifesciences Holdings, Inc. Transaction History

Exodus Point Capital Management, LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$5.11 - $8.76 $2.02 Million - $3.46 Million	395,547 New	395,547 $3.43 Million
Q2 2023 Aug 10, 2023	BUY	$12.09 - $15.0 $2.8 Million - $3.47 Million	231,484 New	231,484 $2.88 Million
Q4 2022 Feb 13, 2023	BUY	$12.5 - $24.78 $1.83 Million - $3.63 Million	146,667 New	146,667 $2.1 Million
Q3 2022 Nov 10, 2022	SELL	$20.6 - $30.37 $1.07 Million - $1.58 Million	-51,924 Closed	0 $0
Q2 2022 Aug 19, 2022	SELL	$26.05 - $37.48 $1.09 Million - $1.57 Million	-41,840 Reduced 44.62%	51,924 $1.48 Million
Q1 2022 May 13, 2022	BUY	$24.46 - $40.92 $2.08 Million - $3.49 Million	85,230 Added 998.71%	93,764 $3.31 Million
Q4 2021 Feb 11, 2022	BUY	$35.0 - $45.94 $298,690 - $392,051	8,534 New	8,534 $358,000
Q3 2021 Nov 15, 2021	SELL	$36.8 - $60.62 $762,827 - $1.26 Million	-20,729 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$32.46 - $45.0 $19,735 - $27,360	-608 Reduced 2.85%	20,729 $865,000
Q1 2021 May 17, 2021	SELL	$25.8 - $38.49 $162,875 - $242,987	-6,313 Reduced 22.83%	21,337 $760,000
Q4 2020 Feb 16, 2021	BUY	$24.5 - $30.86 $677,425 - $853,279	27,650 New	27,650 $776,000

234

140M

223K

19.4K

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $738M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.